These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36496335)

  • 61. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
    Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Ann Oncol; 2013 Sep; 24(9):2376-81. PubMed ID: 23788749
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
    Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
    J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
    Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
    Chung HW; Lee KY; Kim HJ; Kim WS; So Y
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):89-98. PubMed ID: 24194352
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delay.
    Yotsukura M; Nakagawa K; Takemura C; Yoshida Y; Ito K; Watanabe H; Kusumoto M; Yatabe Y; Watanabe SI
    Jpn J Clin Oncol; 2022 Nov; 52(11):1321-1326. PubMed ID: 35975671
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study.
    Wu G; Woodruff HC; Shen J; Refaee T; Sanduleanu S; Ibrahim A; Leijenaar RTH; Wang R; Xiong J; Bian J; Wu J; Lambin P
    Radiology; 2020 Nov; 297(2):451-458. PubMed ID: 32840472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Computed tomography versus frozen sections for distinguishing lung adenocarcinoma: A cohort study of concordance rate.
    Lv YL; Zhang J; Xu K; Jin XY; Zhang XB; Yang HH; Fan XH; Zhang YJ; Li M; Zheng ZC; Huang J; Ye XD; Tao GY; Han YC; Ye B
    Asian J Surg; 2022 Nov; 45(11):2172-2178. PubMed ID: 35346584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status.
    Isaka T; Ito H; Yokose T; Saito H; Adachi H; Murakami K; Miura J; Kikunishi N; Rino Y
    BMC Cancer; 2022 Sep; 22(1):966. PubMed ID: 36085020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
    Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
    Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
    Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C
    Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
    Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pulmonary adenocarcinomas appearing as part-solid ground-glass nodules: is measuring solid component size a better prognostic indicator?
    Hwang EJ; Park CM; Ryu Y; Lee SM; Kim YT; Kim YW; Goo JM
    Eur Radiol; 2015 Feb; 25(2):558-67. PubMed ID: 25274618
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CT assessment-based direct surgical resection of part-solid nodules with solid component larger than 5 mm without preoperative biopsy: experience at a single tertiary hospital.
    Lee SM; Park CM; Song YS; Kim H; Kim YT; Park YS; Goo JM
    Eur Radiol; 2017 Dec; 27(12):5119-5126. PubMed ID: 28656460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma.
    Kinoshita F; Shimokawa M; Takenaka T; Okamoto T; Taguchi K; Oda Y; Yoshizumi T
    Thorac Cancer; 2023 Jun; 14(18):1651-1659. PubMed ID: 37105937
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.